| Home \ Conferences and Programmes \ Intellectual Property \ IP Academy \ IP Meetings |
|
IP MeetingsMSD Israel and Stockholm Network Intellectual Property Academy - Meeting of the Tech-Transfer Group
Date: 22 January 2008
Location: Jerusalem On 22 January 2008, the Technology-Transfer Group of the IP Academy met to deal with the issue of the exploitation of IPRs via public-private partnerships, and specifically by government-owned hospitals.
The group participated in an innovative and simulation that focused on the prioritization the key national components that are essential to tech-transfer activities in public-private partnerships.  MSD Isreal and Stockholm Network Intellectual Property Academy - Meeting of the Tech-Transfer Group
Date: 04 September 2007
Location: Tel-Aviv Speakers: Dr Meir Pugatch, Prof. Avi Israeli, Adv. Yoel Lipschitz, Dr. Itzhak Zaidise, Mr. Jacov Mulaem, Adv. Adva Perry, Mr. Netta Cohen, Ms. Nava Swersky Sofer, Dr. Michal Roll, Mr. Pini Ben-Elazar, Dr. Sylvie Luria, Ms. Rachel Diamant, Dr. Yoav Shechter This meeting studied the most important elements for building a successful technology-transfer model that involves collaboration between government owned hospitals and private bodies.
The Process of Intellectual Property Policy-Making
Date: 22 June 2006
Location: Jerusalem Speakers: Prof. Michael Blakeney, Director, Queen Mary Intellectual Property Research Institute, University of London; Mr. Jon Sandelin, Senior Associate Emeritus, Stanford University Office of Technology Licensing; This meeting studied the political process of intellectual property policy-making, and in particular, the means by which different government agencies with responsibilities in the IP field can best co-ordinate their activities.
Intellectual property policy-making in an environment with a dual structured pharmaceutical industry (innovative and generic)
Date: 16 February 2006
Location: Tel Aviv Speakers: Prof. Kenneth Kaitin, Director, Tufts Center for the Study of Drug Development; Mr. Barun Mitra, Founder/Director, Liberty Institute (www.libertyindia.org); Prof. Avi Israeli, Director, Ministry of Health This meeting studied the processes of intellectual property policy-making in an environment with a dual structured pharmaceutical industry – research based and generic-based pharmaceutical companies.
The strength of intellectual property environments and foreign direct investment
Date: 28 September 2005
Location: Tel Aviv Speakers: Mr. Douglas Lippoldt, Senior Trade Analyst, OECD Trade and Investment Directorate; Mr Jim Whelan, Business Development Manager, Irish Development Agency (IDA); Mr Jacob Harel, Senior Director, Merck Business Development Division. The theme of the first session was the correlation between the strength of an intellectual property regime and foreign direct investment (FDI) in a given country
|
Read the full write-up of the meeting
© 2008 The Stockholm Network